# OnCo record bmt-ctn-0803 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/bmt-ctn-0803/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "bmt-ctn-0803", "NCT01141712" ;
  schema:name "BMT CTN 0803"@en ;
  schema:alternateName "BMTCTN0803"@en, "CTN 0803"@en, "AMC 071"@en ;
  schema:description "BMT CTN 0803 showed that people living with HIV whose lymphoma had come back can have the same high-dose chemotherapy and stem cell transplant as anyone else, with 87 percent alive at one year and outcomes no different from matched HIV-negative patients, so HIV alone should not bar transplant."@en ;
  schema:url <https://onco.cc/trials/bmt-ctn-0803/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01141712> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/hiv-associated-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/carmustine/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/melphalan/> ;
  onco:institutions <https://onco.cc/institutions/mcw-cancer-center/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-bmt-ctn-0803-autologous-transplant-hiv-lymphoma-alvarnas-blood-2016/> .